ACP5 and systemic lupus erythematosus: Collectively, these results further suggest that ACP5 and SAMHD1 can synergistically regulate the type I IFN pathway and that genetic alteration in these two genes accumulate susceptibility to SLE through dysregulation of the IFN pathway (Figure 4C).